BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to All Ratios
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Cash Profit Margin History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Profit Margin (%) | -36.85 | -10.90 | -20.95 | -14.92 | -6.60 |
What is the latest Cash Profit Margin ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Cash Profit Margin |
---|---|
Mar2023 | -36.85 |
Mar2022 | -10.90 |
Mar2021 | -20.95 |
Mar2020 | -14.92 |
Mar2019 | -6.60 |
How is Cash Profit Margin of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Cash Profit Margin | % Change | |
---|---|---|---|
Mar2023 | -36.85 | Negative | |
Mar2022 | -10.9 | Negative | |
Mar2021 | -20.95 | Negative | |
Mar2020 | -14.92 | Negative | |
Mar2019 | -6.6 | - |
Other Financial Ratios of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹96.8 Cr | -10.2% | -9.2% | -34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -10.2% |
-9.2% |
-34.2% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses